ACTAVIS MID ATLANTIC FDA Approval ANDA 074075

ANDA 074075

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #074075

Application Sponsors

ANDA 074075ACTAVIS MID ATLANTIC

Marketing Status

Discontinued001

Application Products

001SYRUP;ORALEQ 0.5MG BASE/5ML0CLEMASTINE FUMARATECLEMASTINE FUMARATE

FDA Submissions

ORIG1AP1993-10-31
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2000-03-27
LABELING; LabelingSUPPL5AP2000-03-27
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2000-03-27
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-12-04

Submissions Property Types

SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74075
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLEMASTINE FUMARATE","activeIngredients":"CLEMASTINE FUMARATE","strength":"EQ 0.5MG BASE\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CLEMASTINE FUMARATE","submission":"CLEMASTINE FUMARATE","actionType":"EQ 0.5MG BASE\/5ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.